# Telomir Pharmaceuticals, Inc. Common Stock (TELO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TELO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -2.71M | $ -2.79M | $ 0 | $ 5.03M |
| 2025 | $ 0 | $ -10.66M | $ -3.78M | $ 473.8K | $ 5.91M |
| 2024 | $ 0 | $ -17.44M | $ -5.33M | $ 93.4K | $ 643.0K |
| 2023 | $ 0 | $ -14.13M | $ -4.17M | $ 101.0K | $ 3.44M |
| 2022 | $ 0 | $ -954.2K | $ -523.5K | $ 0 | $ -937.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.07 |
| Current Ratio | 16.14 |

## Other views

- [Metrics](https://sponda.capital/en/TELO.md)
- [Charts](https://sponda.capital/en/TELO/charts.md)
- [Compare](https://sponda.capital/en/TELO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.